Amarin | AMRN - Saham





Saham Perubahan Tanggal
AbbVie USD 4.95B 13M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
AstraZeneca USD 6.59B 126M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09